December 11, 2020

Temporal Patterns of Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.

By Dylan

Background Transforming biomarkers carry excessive potential for predicting hostile occasions in persistent coronary heart failure ( CHF ) sufferers. Nonetheless, temporal patterns throughout the course of CHF , and particularly the trajectory earlier than an hostile occasion, are unknown. We studied the prognostic worth of temporal patterns of cardiac reworking biomarker candidates in steady sufferers with CHF from the Bio-SHiFT (Serial Biomarker Measurements and New Echocardiographic Methods in Persistent Coronary heart Failure Sufferers End in Tailor-made Prediction of Prognosis) research. Strategies and Outcomes In 263 CHF sufferers, we carried out trimonthly blood sampling throughout a median follow-up of two.2 years.

For the evaluation, we chosen all baseline samples, the two samples closest to the first finish level ( PE ), or the final pattern out there for finish point-free sufferers. Thus, in 567 samples, we measured suppression of tumorigenicity-2, galectin-3, galectin-4, progress differentiation factor-15, matrix metalloproteinase-2, 3, and 9, tissue inhibitor metalloproteinase-4, perlecan, aminopeptidase-N, <em>caspase</em>-3, cathepsin-D, cathepsin-Z, and cystatin-B. The PE was a composite of cardiovascular mortality, coronary heart transplantation, left ventricular help machine implantation, and HF hospitalization. Associations between repeatedly measured biomarker candidates and the PE had been investigated by joint modeling. Median age was 68 (interquartile vary: 59-76) years with 72% males; 70 sufferers reached the PE . Repeatedly measured suppression of tumorigenicity-2, galectin-3, galectin-4, progress differentiation factor-15, matrix metalloproteinase-2 and 9, tissue inhibitor metalloproteinase-4, perlecan, cathepsin-D, and cystatin-B ranges had been considerably related to the PE , and elevated because the PE approached. The slopes of biomarker trajectories had been additionally predictors of scientific end result, impartial of their absolute stage. Associations continued after adjustment for scientific traits and pharmacological therapy.

Suppression of tumorigenicity-2 was the strongest predictor (hazard ratio: 7.55 per SD distinction, 95% CI : 5.53-10.30), adopted by progress differentiation factor-15 and matrix metalloproteinase-2. Conclusions Temporal patterns of reworking biomarker candidates predict hostile scientific outcomes in CHF. JNK and its downstream transcriptional elements together with c-Jun, activating transcription issue 2 (ATF2), and JunD had been all considerably phosphorylated in CIH rats. Nonetheless, pretreatment of NF-κB inhibitor BAY 11-7082 inhibited the activation of NF-κB below CIH situation and likewise considerably decreased the phosphorylation of JNK in addition to c-Jun, ATF2, and JunD.

 

Novel compound VB-037 inhibits Aβ aggregation and promotes neurite outgrowth via enhancement of HSP27 and discount of P38 and JNK-mediated irritation in cell fashions for Alzheimer’s illness.

The pathogenesis of Alzheimer’s illness (AD) is concerned within the aggregation of misfolded amyloid β (Aβ), which upregulates the exercise of acetylcholinesterase (AChE), will increase the manufacturing of reactive oxygen species (ROS), enhances neuroinflammation, and finally results in neuronal dying. Due to this fact, compounds concentrating on these mechanisms could also be candidates for multitarget medication in AD therapy. We discovered that two quinoline derivatives, VB-030 and VB-037, markedly decreased Aβ aggregation and ROS ranges within the thioflavin T biochemical assay and Tet-On Aβ-green fluorescent protein (GFP) 293 AD cell mannequin. These compounds additional improved neurite outgrowth, decreased AChE exercise and upregulated the molecular chaperone warmth shock protein household B [small] member 1 (HSP27), whereas knockdown of HSP27 counteracted the compounds’ neuroprotective results on the Tet-On neuronal mannequin. Moreover, VB-037 attenuated lipopolysaccharide (LPS)/interferon (IFN)-γ-induced activation of BV-2 microglial cells.
As well as, VB-037 demonstrated its potential to decrease LPS/IFN-γ-induced upregulation of <em>caspase</em> 1 exercise, expression of interleukin (IL)-1β, and lively phosphorylation of mitogen-activated protein kinase <em>14</em> (P38), mitogen-activated protein kinase 8 (JNK), and Jun proto-oncogene, AP-1 transcription issue subunit (JUN) signalings, in addition to enhance cell viability within the Tet-On neuronal mannequin. Our findings strongly point out the potential of VB-037 for modifying AD development by concentrating on a number of mechanisms, thereby providing a brand new drug improvement avenue for AD therapy. Hepatitis B virus X (HBx), a viral onco-protein encoded by HBV, can promote oncogenesis of HCC. Nonetheless, the mechanism of HBx in hepatocarcinogenesis remains to be unclear. On this research, we set up a brand new mouse mannequin with regular immune system to analyze the position of HBx and its purposeful mechanisms below regular immune operate.
The animal mannequin was established by injecting HBx-EGFP-<em>14</em>-19 cells into the hepatic portal vein of KM mice. To confirm the mouse mannequin, the expression of HBx within the liver tissue of mice was detected by qRT-PCR, western blotting and immunohistochemistry. The apoptosis index was calculated utilizing the terminal deoxynucleotidyl transferase-dUTP nick-end labeling (TUNEL) assay, and the expression ranges of apoptosis-related and cell cycle-related elements had been measured.

Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy by way of the Hedgehog pathway.

Research relating to macroautophagic/autophagic regulation in endothelial cells (ECs) below diabetic circumstances are very restricted. Medical proof establishes an endothelial protecting impact of metformin, however the underlying mechanisms stay unclear. We aimed to analyze whether or not metformin exerts its protecting position in opposition to hyperglycemia-induced endothelial impairment via the autophagy equipment. db/db mice had been handled with intravitreal metformin injections. Human umbilical vein endothelial cells (HUVECs) had been cultured both in regular glucose (NG, 5.5 mM) or excessive glucose (HG, 33 mM) medium within the presence or absence of metformin for 72 h. We noticed an apparent inhibition of hyperglycemia-triggered autophagosome synthesis in each the diabetic retinal vasculature and cultured HUVECs by metformin, together with restoration of hyperglycemia-impaired Hedgehog (Hh) pathway exercise.
Particularly, deletion of ATG7 in retinal vascular ECs of db/db mice and cultured HUVECs indicated a detrimental position of autophagy in hyperglycemia-induced endothelial dysfunction. Pretreatment with GANT61, a Hh pathway inhibitor, abolished the metformin-mediated downregulation of autophagy and endothelial protecting motion. Moreover, GLI-family (transcription elements of the Hh pathway) knockdown in HUVECs and retinal vasculature revealed that downregulation of hyperglycemia-activated autophagy by the metformin-mediated Hh pathway activation was GLI1 dependent. Mechanistically, GLI1 knockdown-triggered autophagy was associated to upregulation of BNIP3, which subsequently disrupted the affiliation of BECN1/Beclin 1 and BCL2.

Caspase 12 antibody

70R-11740 100 ug
EUR 392
Description: Rabbit polyclonal Caspase 12 antibody

Caspase 12 antibody

70R-51166 100 ul
EUR 242
Description: Purified Polyclonal Caspase 12 antibody

Caspase 12 antibody

20R-1513 100 ug
EUR 807.6
Description: Rabbit polyclonal Caspase 12 antibody

Caspase 12 Antibody

48277 100ul
EUR 429

Caspase 12 antibody

CAF50516-100ug 100ug
EUR 312

Caspase 12 Antibody

E8RT1095 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 12 Antibody

E38PA2847 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 12, Antibody

GWB-928C1B 1 ml Ask for price

Caspase 12 Antibody

GWB-F74468 0.05 ml Ask for price

Caspase 12 Antibody

MBS5311249-01mg 0.1mg
EUR 525

Caspase 12 Antibody

MBS5311249-5x01mg 5x0.1mg
EUR 2325

Caspase 12 Antibody

MBS5315784-01mL 0.1mL
EUR 470

Caspase 12 Antibody

MBS5315784-5x01mL 5x0.1mL
EUR 1955

Caspase 12 Antibody

MBS8581604-01mL 0.1mL
EUR 305

Caspase 12 Antibody

MBS8581604-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 12 Antibody

MBS8581604-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 12 Antibody

MBS8581604-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 12 Antibody

MBS8581604-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 12 Antibody

MBS9459373-005mL 0.05mL
EUR 325

Caspase 12 Antibody

MBS9459373-01mL 0.1mL
EUR 445

Caspase 12 Antibody

MBS9459373-5x01mL 5x0.1mL
EUR 1860

Caspase 12 Antibody

R36146-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: CASP12

Caspase-12 Antibody

24119-100ul 100ul
EUR 468

Caspase-12 Antibody

24120-100ul 100ul
EUR 468

Caspase-12 Antibody

2325-002mg 0.02 mg
EUR 206.18
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues.

Caspase-12 Antibody

2325-01mg 0.1 mg
EUR 523.7
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues.

Caspase-12 Antibody

2327-002mg 0.02 mg
EUR 206.18
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta.

Caspase-12 Antibody

2327-01mg 0.1 mg
EUR 523.7
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta.

Caspase-12 Antibody

3282-100 each
EUR 424.8

Caspase-12 Antibody

3282-30T each
EUR 175.2

Caspase-12 Antibody

E90556 100ul
EUR 255
Description: Available in various conjugation types.

CASPASE-12 Antibody

GWB-A00599 0.05 mg Ask for price

CASPASE-12 Antibody

GWB-A22692 0.1 mg Ask for price

CASPASE-12 Antibody

GWB-CD9AC6 0.1 mg Ask for price

Caspase-12 Antibody

MBS150406-01mg 0.1mg
EUR 445

Caspase-12 Antibody

MBS150406-5x01mg 5x0.1mg
EUR 1965

Caspase-12 Antibody

MBS150532-01mg 0.1mg
EUR 445

Caspase-12 Antibody

MBS150532-5x01mg 5x0.1mg
EUR 1965

Caspase-12 Antibody

MBS8503096-01mL 0.1mL
EUR 325

Caspase-12 Antibody

MBS8503096-01mLAF405L 0.1mL(AF405L)
EUR 565

Caspase-12 Antibody

MBS8503096-01mLAF405S 0.1mL(AF405S)
EUR 565

Caspase-12 Antibody

MBS8503096-01mLAF610 0.1mL(AF610)
EUR 565

Caspase-12 Antibody

MBS8503096-01mLAF635 0.1mL(AF635)
EUR 565

Caspase-12 Antibody

MBS9409151-01mL 0.1mL
EUR 495

Caspase-12 Antibody

MBS9409151-5x01mL 5x0.1mL
EUR 2075

Caspase-12 Antibody

MBS9409370-01mL 0.1mL
EUR 495

Caspase-12 Antibody

MBS9409370-5x01mL 5x0.1mL
EUR 2075

Caspase-12 Antibody (Large)

3195-002mg 0.02 mg
EUR 206.18
Description: Caspase-12 Antibody: (Large)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues.

Caspase-12 Antibody (Large)

3195-01mg 0.1 mg
EUR 523.7
Description: Caspase-12 Antibody: (Large)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues.

Caspase-12 Antibody (Small)

3197-002mg 0.02 mg
EUR 206.18
Description: Caspase-12 Antibody: (Small)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues.

Caspase-12 Antibody (Small)

3197-01mg 0.1 mg
EUR 523.7
Description: Caspase-12 Antibody: (Small)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues.

Caspase-12 Antibody (Large)

24208-100ul 100ul
EUR 468

Caspase-12 Antibody (Small)

24209-100ul 100ul
EUR 468

Caspase-12 Antibody (Small)

MBS150848-01mg 0.1mg
EUR 445

Caspase-12 Antibody (Small)

MBS150848-5x01mg 5x0.1mg
EUR 1965

Caspase-12 Antibody (Large)

MBS151444-01mg 0.1mg
EUR 445

Caspase-12 Antibody (Large)

MBS151444-5x01mg 5x0.1mg
EUR 1965

Caspase-12 Antibody (Large)

MBS9401397-01mL 0.1mL
EUR 495

Caspase-12 Antibody (Large)

MBS9401397-5x01mL 5x0.1mL
EUR 2075

Caspase-12 Antibody (Small)

MBS9405551-01mL 0.1mL
EUR 495

Caspase-12 Antibody (Small)

MBS9405551-5x01mL 5x0.1mL
EUR 2075

Rabbit anti Caspase 12 Polyclonal Antibody

MBS460304-01mg 0.1mg
EUR 320

Rabbit anti Caspase 12 Polyclonal Antibody

MBS460304-5x01mg 5x0.1mg
EUR 1390

Rabbit anti Caspase 12 Polyclonal Antibody

TA354439 100 µg Ask for price

Polyclonal Caspase-12 Antibody

APR06275G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 . This antibody is tested and proven to work in the following applications:

Polyclonal Caspase-12 Antibody

APR06276G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 . This antibody is tested and proven to work in the following applications:

Polyclonal Caspase-12 Antibody

APR00058G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 . This antibody is tested and proven to work in the following applications:

Caspase 12 (CASP12) Antibody

abx026563-400l 400 µl
EUR 518.75

Caspase 12 (CASP12) Antibody

abx026563-400ul 400 ul
EUR 627.6

Caspase 12 (CASP12) Antibody

abx026563-80l 80 µl
EUR 250

Caspase 12 (CASP12) Antibody

abx111421-100l 100 µl
EUR 612.5

Caspase 12 (CASP12) Antibody

20-abx111421
  • Ask for price
  • Ask for price
  • 50 ul
  • 150 ul

Caspase 12 (CASP12) Antibody

abx129818-100l 100 µl
EUR 262.5

Caspase 12 (CASP12) Antibody

20-abx129818
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (CASP12) Antibody

abx129818-1ml 1 ml
EUR 687.5

Caspase 12 (CASP12) Antibody

abx129818-200l 200 µl
EUR 325

Caspase 12 (CASP12) Antibody

abx100899-100l 100 µl
EUR 262.5

Caspase 12 (CASP12) Antibody

20-abx100899
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (CASP12) Antibody

abx100899-1ml 1 ml
EUR 725

Caspase 12 (CASP12) Antibody

abx100899-200l 200 µl
EUR 337.5

Caspase 12 (Casp12) Antibody

abx318989-100l 100 µl
EUR 250

Caspase 12 (Casp12) Antibody

20-abx318989
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (Casp12) Antibody

abx318989-50l 50 µl
EUR 162.5

Caspase 12 (CASP12) Antibody

abx318255-100g 100 µg
EUR 362.5

Caspase 12 (CASP12) Antibody

20-abx318255
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (CASP12) Antibody

abx318255-20g 20 µg
EUR 162.5

Caspase 12 (CASP12) Antibody

abx318255-50g 50 µg
EUR 250

Caspase 12 (CASP12) Antibody

abx324638-100g 100 µg
EUR 250

Caspase 12 (CASP12) Antibody

20-abx324638
  • Ask for price
  • Ask for price
  • 50 ug
  • 100 ug

Caspase 12 (CASP12) Antibody

abx324638-50g 50 µg
EUR 187.5

Caspase 12 (CASP12) Antibody

abx216233-100ug 100 ug
EUR 526.8

Caspase 12 (CASP12) Antibody

abx213378-100g 100 µg
EUR 250

Caspase 12 (CASP12) Antibody

20-abx213378
  • Ask for price
  • Ask for price
  • 50 ul
  • 100 ul

Caspase 12 (CASP12) Antibody

abx231286-100g 100 µg
EUR 350

Caspase 12 (CASP12) Antibody

abx210324-100l 100 µl
EUR 350

Caspase 12 (CASP12) Antibody

20-abx210324
  • Ask for price
  • Ask for price
  • 50 ul
  • 100 ul

Caspase 12 (CASP12) Antibody

abx210324-50l 50 µl
EUR 250

Caspase-12 polyclonal antibody

BS3542 50 ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Caspase-12 Polyclonal Antibody

BS65665 50ul
EUR 358
Description: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Caspase-12 Polyclonal Antibody

E-AB-64000-120uL 120uL
EUR 320
Description: Unconjugated

Caspase-12 Polyclonal Antibody

E-AB-64000-200uL 200uL
EUR 530
Description: Unconjugated

Caspase-12 Polyclonal Antibody

E-AB-64000-60uL 60uL
EUR 200
Description: Unconjugated

Caspase-12 Polyclonal Antibody

E-AB-64000-each each Ask for price
Description: Unconjugated

Caspase-12 Polyclonal Antibody

MBS668045-0025mg 0.025mg
EUR 175

Caspase-12 Polyclonal Antibody

MBS668045-01mg 0.1mg
EUR 325

Caspase-12 Polyclonal Antibody

MBS668045-5x01mg 5x0.1mg
EUR 1465

Caspase-12 Polyclonal Antibody

RD79981A-120uL 120μL
EUR 360
Description: Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF.

Caspase-12 Polyclonal Antibody

RD79981A-200uL 200μL
EUR 630
Description: Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF.

Caspase-12 Polyclonal Antibody

RD79981A-60uL 60μL
EUR 204
Description: Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF.

Caspase 12 Polyclonal Antibody

ABP50853-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Caspase 12 from Human. This Caspase 12 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase12

Caspase 12 Polyclonal Antibody

ABP50853-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Caspase 12 from Human. This Caspase 12 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase12

Caspase 12 Polyclonal Antibody

ABP50853-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Caspase 12 from Human. This Caspase 12 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase12

Caspase 12 Polyclonal Antibody

ABP50853-100uL 100 μL
EUR 239
Description: Rabbit Anti-Caspase12 Polyclonal Antibody

Caspase 12 Polyclonal Antibody

ABP50853-200uL 200 μL
EUR 379
Description: Rabbit Anti-Caspase12 Polyclonal Antibody

Caspase 12 Polyclonal Antibody

ABP50853-30uL 30 μL
EUR 109
Description: Rabbit Anti-Caspase12 Polyclonal Antibody

Caspase 12 polyclonal antibody

MBS565870-01mg 0.1mg
EUR 520

Caspase 12 polyclonal antibody

MBS565870-5x01mg 5x0.1mg
EUR 2290

Rabbit anti-mouse Caspase-12 polyclonal Antibody(Casp12)

MBS1498584-005mg 0.05mg
EUR 190

Rabbit anti-mouse Caspase-12 polyclonal Antibody(Casp12)

MBS1498584-01mg 0.1mg
EUR 270

Rabbit anti-mouse Caspase-12 polyclonal Antibody(Casp12)

MBS1498584-5x01mg 5x0.1mg
EUR 1205

Polyclonal Caspase-12 Antibody (Large)

APR06327G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 (Large). This antibody is tested and proven to work in the following applications:

Polyclonal Caspase-12 Antibody (Small)

APR06328G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 (Small). This antibody is tested and proven to work in the following applications:

Caspase 12 (CASP12) Antibody (HRP)

abx316303-100g 100 µg
EUR 362.5

Caspase 12 (CASP12) Antibody (HRP)

20-abx316303
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (CASP12) Antibody (HRP)

abx316303-20g 20 µg
EUR 162.5

Caspase 12 (CASP12) Antibody (HRP)

abx316303-50g 50 µg
EUR 250

Caspase 12 (Casp12) Antibody (HRP)

abx318990-100l 100 µl
EUR 250

Caspase 12 (Casp12) Antibody (HRP)

20-abx318990
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (Casp12) Antibody (HRP)

abx318990-50l 50 µl
EUR 162.5

Rabbit Polyclonal Caspase-12 Antibody

TA306052 100 µg Ask for price

Rabbit Polyclonal Caspase-12 Antibody

TA306053 100 µg Ask for price

Caspase 12 (CASP12) Antibody (FITC)

abx316304-100g 100 µg
EUR 362.5

Caspase 12 (CASP12) Antibody (FITC)

20-abx316304
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (CASP12) Antibody (FITC)

abx316304-20g 20 µg
EUR 162.5

Caspase 12 (CASP12) Antibody (FITC)

abx316304-50g 50 µg
EUR 250

Caspase 12 (Casp12) Antibody (FITC)

abx318991-100l 100 µl
EUR 250

Caspase 12 (Casp12) Antibody (FITC)

20-abx318991
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (Casp12) Antibody (FITC)

abx318991-50l 50 µl
EUR 162.5

Rabbit Anti Caspase-12 (Aa100-116) Polyclonal Antibody

CPBT-66303RC 0.1 mg
EUR 540.54
Description: Rabbit

Caspase 12 (CASP12) Antibody (Biotin)

abx316305-100g 100 µg
EUR 362.5

Caspase 12 (CASP12) Antibody (Biotin)

20-abx316305
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Caspase 12 (CASP12) Antibody (Biotin)

abx316305-20g 20 µg
EUR 162.5

Caspase 12 (CASP12) Antibody (Biotin)

abx316305-50g 50 µg
EUR 250

Caspase 12 (Casp12) Antibody (Biotin)

abx318992-100l 100 µl
EUR 250
The position of BNIP3 in BECN1 dissociation from BCL2 was additional confirmed by BNIP3 overexpression or BNIP3 RNAi. Taken collectively, the endothelial protecting impact of metformin below hyperglycemia circumstances could possibly be partly attributed to its position in downregulating autophagy by way of Hh pathway activation. Abbreviations: 3-MA = 3-methyladenine; 8×GLI BS-FL = 8×GLI-binding website firefly luciferase; AAV = adeno-associated virus; AAV-Cdh5-sh-Atg7 = AAV vectors carrying shRNA in opposition to murine Atg7 below management of murine Cdh5 promoter.

 

 

 

 

Dylan